IBM announced its fourth major heal data-related acquisition in the part year: Truven Health Analytics, a leading provider of cloud-based healthcare data, analytics and insights. The price was $2.6 billion.
IBM plans to integrate Truven’s extensive cloud-based data set spanning hundreds of different types of cost, claims, quality and outcomes information with its existing data sets.
Upon completion of the acquisition, IBM’s health cloud will house one of the world’s largest and most diverse collections of health-related data, representing an aggregate of approximately 300 million patient lives acquired from three companies (aggregate figure includes roughly 215 million patient lives from Truven, 50 million patient lives from Explorys and 45 million patient lives from Phytel).
“With this acquisition, IBM will be one of the world’s leading health data, analytics and insights companies, and the only one that can deliver the unique cognitive capabilities of the Watson platform,” said Deborah DiSanzo, general manager for IBM Watson Health.
http://www.ibm.com/smarterplanet/us/en/ibmwatson/health/
IBM to add Medical Imaging to Watson
IBM agreed to acquire Merge Healthcare Incorporated (NASDAQ: MRGE), a leading provider of medical image handling and processing, interoperability and clinical systems for $7.13 per share in cash, for a total transaction value of $1 billion.
IBM said the deal will provide Watson with the ability to “see” by bringing together Watson’s advanced image analytics and cognitive capabilities with data and images obtained from Merge’s medical imaging management platform. Merge’s technology platforms are used at more than 7,500 U.S. healthcare sites, as well as most of the world’s leading clinical research institutes and pharmaceutical firms to manage a growing body of medical images. The vision is that these organizations could use the Watson Health Cloud to surface new insights from a consolidated, patient-centric view of current and historical images, electronic health records, data from wearable devices and other related medical data, in a HIPAA-enabled environment.
“As a proven leader in delivering healthcare solutions for over 20 years, Merge is a tremendous addition to the Watson Health platform. Healthcare will be one of IBM’s biggest growth areas over the next 10 years, which is why we are making a major investment to drive industry transformation and to facilitate a higher quality of care,” said John Kelly, senior vice president, IBM Research and Solutions Portfolio. “Watson’s powerful cognitive and analytic capabilities, coupled with those from Merge and our other major strategic acquisitions, position IBM to partner with healthcare providers, research institutions, biomedical companies, insurers and other organizations committed to changing the very nature of health and healthcare in the 21st century. Giving Watson ‘eyes’ on medical images unlocks entirely new possibilities for the industry.”
http://www.merge.com/
